Peer Review History
| Original SubmissionJune 14, 2025 |
|---|
|
Dear Dr. Selim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR:Please, revise the manuscript accordingly to the reviewers comments (including the comments provided by myself) ============================== Please submit your revised manuscript by Sep 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Gianmarco Ferrara Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on methods of anesthesia and/or analgesia 3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 4. In the online submission form, you indicated that “available from corresponding author on request” All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either; 1. In a public repository 2. Within the manuscript itself 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: One reviewer have problems in the loading the report. Their comments are as follows: General comment: water buffalo are an integral part of Egyptian livestock Did the authors investigate the possible effects of climate change on the seroprevalence and transmission dynamics? Additional knowledge gained from including other susceptible animals (goats, as was done for cattle) or at least a statement of the seroprevalence of the problem in these species would have added value to the results and a comparative aspect of the problem across species. Good and well written article which should qualify for publication as a short communication. It requires more work to qualify as a peer reviewed journal article. Eg • comparison of buffalo and cattle and goat seroprevalence • indications and elaboration on routes of transmission and extent of problem in humans • the effect of climate change on the transmission dynamics of the disease and preparedness steps that can be taken. Line 71 Benha University and every where else where this appears 78 Study design must be bold This qualifies as a short communication [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The manuscript entitled “Risk Factors Influencing Coxiella burnetii Seropositivity in Buffalo Populations of Egypt’s Nile Delta” is clear and well written. The methodology is adequate. The discussion is clear and objective. Below are minor comments for consideration. Comments: Line 99: Please consider including the blood collection volume, tube type, and site (ie. Tail vein, jugular vein, etc..). Lines 93 and 100: This states that cattle were sampled and blood was collected from cattle, respectively. Shouldn’t this be from buffalo? Line 104: It may be helpful to have the questionnaire available for to the reader, if possible. Line 108: Please include a statement and/or include references that clarifies to the reader that the IDEXX kit works for buffalo serum. The test has been used with buffalo serum in other studies, but the extra clarity for the reader would be useful since the manufacturer specifies its use in sheep, goats, and cattle. Line 127: Please include how confounders were handled. Lines 138 – 151: Please include clarity throughout this section so the reader knows this is based on univariable analysis. Similarly, please clarify in the title of Table 1 as well. Lines 190-195: Suggest removing this section since the findings were not at the significance threshold set by the authors. Lines 193 and 229: Please include a reference to support the statements that pregnant females have greater susceptibility to C. burnetii infection. Line 238: The statement that female sex is significantly associated with infection does not align with the results section or Tables. Additionally, infection status of the animals is not assessed in this study, rather seropositivity. Table 1: - Suggest removing “locality” from the first row. - The > before 5-8 should be removed. Same for Table 2. Same for line 106. - How is tick infestation defined? Please clarify somewhere in the manuscript. Is it the presence of any ticks or > a certain number? Is the status determined at the time of blood collection? - yes in the “History of abortion in previous year” row is lowercase. - The inconsistency between the position of Yes and No in the rows for Tick infestation could lead to confusion since it is different from the other variables. Reviewer #2: The authors have tried to summarize risk factors that can cause or influence Coxiella burnetii positive in buffalo serum. Though, there are some points that should be included or added in the manuscript. Major points: - The authors detected Coxiella burnetii antibodies in buffalo serum samples using a commercial indirect ELISA. It would be nice if they can include or at least perform PCR reaction in DNA extraction of blood sample (additional from serum) and sequence the samples to confirm the sequence of DNA that showed Coxiella bunetii positive. No need to sequence all the samples but at least some to confirm the results. - The Coxiella bunetii DNA sequence can provide additional valuable information and analyze further to increase the impact of this research/manuscript. - Even though, the Ethics approval is mentioned, the authors should add the “protocol number” of this research, especially this manuscript is dealing with buffaloes which are mammals. -There are still more factors that should be considered, such as, the way the buffalo live, antibiotic treated and etc. Though, the authors did not measure these factors but they should discuss or include the background of these factors in the population being studied. Minor points: - Please keep the consistency of how to write the word Coxiella burnetii, “full name” or “abbreviated” when mentioned for the first time and later. - Add full word of “OR” in text - Add GPS for each location being studied - Add genus of the buffalo - Table 1 heading, write the full word of “CI” - How big of the number of tick sample for tick infestation? - What the authors mean by presence of small ruminants? Reviewer #3: The manuscript presents an important investigation on C. burnetii in water buffalo, which has an important public health significance; however, several improvements in structure, clarity, and language are necessary to enhance its scientific value and reproducibility. Abstract • Line 23-24: Please rewrite “Buffaloes over 8 years of age showed a higher prevalence (21.6%) compared to the younger age groups” Materials and methods • Line 93: Authors quoted “conducted using a convenient sample of cattle, selected through simple random sampling from herds…”. Did they mean a convenient sample of the herds and a random sampling of animals within herds? Please explain how this was actually done to make the study reproducible. • Line 99-100: A more details of sample collection is required, volume of each sample collected in which type of container (e.g., EDTA or clot activator etc.), who collected the samples, was the samples taken in ice box immediately, and a time range within which the samples were processed in lab for centrifugation, and how long the samples were stored in -20°C before serological analysis? • Line 128-134: The Authors did not address confounding, interaction, and collinearity for the final regression model. If any confounding is found that variable must be included in the final model to correct for the confounding effect. If there is collinearity, only one variable should be chosen to eliminate the duplication of effects. • For me, this is actually a multivariable regression, not multivariate, since the outcome is binary (yes/no) Results • Line 413 Table 2: Please keep the reference category for each variable in the table to make the comparison easily understandable. Please improve the table captions e.g., Multivariable logistic regression analysis for C. burnetii regressed against four variables as risk factors from N=(440) buffaloes in four governorates in Egypt’s Nile Delta • Line 415: CI: 95% Confidence intervals • Results of confounding and collinearity check should be mentioned in results Discussion • My suggestions are that the discussion may start with a brief paragraph on the important findings, especially the higher prevalence and risk factors how it could be important for the perspective of the study population. This partly done in line 165-167 where author can specify the risk factors e.g., older buffaloes, communal grazing area, presence of tick infestation, small ruminants, and previous history of abortion. • Line 171 “Seroprevalence rate” rate should be carefully interpreted, rate usually is relevant to incidence, which is different from prevalence. • Could the ELISA be a limitation for example, antibody may not always represent actual presence of the pathogen and since the Se and Sp of ELISA might be lower than PCR? The authors may also report this, which could result in a minor underestimation or overestimation of actual prevalence. • Line 184-188: Authors may explain the source of variations e.g., “Environmental factors, including climate and geography, also play a role in disease transmission.” How the transmission occurs in response to 1 or 2 of those important variables. • “discrepancies in diagnostic tools, testing protocols, sample sizes, and study designs can lead to differing results ” Similarly here, authors may explain here 1 or 2 of those important variables. That will make the discussion more informative. • Line 204-207 “Additionally, vaginal discharges, …… animals during communal grazing [43].” Does it mean that in communal grazing, the management seems more difficult than in non-grazing? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Shuvo Singha ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Selim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Gianmarco Ferrara Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Some previous comments have been not addressed. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes ********** Reviewer #1: A number of comments from the previous round were not addressed. Please see them below. Lines 93 and 100: This states that cattle were sampled and blood was collected from cattle, respectively. Shouldn’t this be from buffalo? - Line 101 states cattle were sampled. Line 127: Please include how confounders were handled. - No response was provided. Lines 138 – 151: Please include clarity throughout this section so the reader knows this is based on univariable analysis. Similarly, please clarify in the title of Table 1 as well. - No response was provided. Lines 190-195: Suggest removing this section since the findings were not at the significance threshold set by the authors. - No response was provided. Lines 193 and 229: Please include a reference to support the statements that pregnant females have greater susceptibility to C. burnetii infection. Not addressed - No response was provided. Line 238: The statement that female sex is significantly associated with infection does not align with the results section or Tables. Additionally, infection status of the animals is not assessed in this study, rather seropositivity. - No response was provided. Table 1: - The > before 5-8 should be removed. Same for Table 2. Same for line 106. - How is tick infestation defined? Please clarify somewhere in the manuscript. Is it the presence of any ticks or > a certain number? Is the status determined at the time of blood collection? - yes in the “History of abortion in previous year” row is lowercase. New Comments - Line 101: please clarify what pf stands for. Reviewer #3: No further comments on the updated version. Thanks to the authors for sufficiently revising the manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #3: Yes: Shuvo Singha ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Dear Dr. Selim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Gianmarco Ferrara Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: I personally reviewed the latest revisions submitted by the authors (due to the unavailability of reviewer #1). The authors did not submit a "track changes manuscript" (the two uploaded files are identical). Furthermore, some comments were not addressed. I ask the authors to address all reviewer comments and reflect these changes in the manuscript, marking them with the track changes tag. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Risk Factors Influencing Coxiella burnetii Seropositivity in Buffalo Populations of Egypt's Nile Delta PONE-D-25-32343R3 Dear Dr. Abdelfattah Selim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Gianmarco Ferrara Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-32343R3 PLOS ONE Dear Dr. Selim, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Gianmarco Ferrara Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .